Search

Collegium Pharmaceutical Inc

Закрыт

СекторЗдравоохранение

27.33 0.48

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

26.69

Макс.

27.95

Ключевые показатели

By Trading Economics

Доход

-30M

-15M

Продажи

6.4M

200M

P/E

Средняя по отрасли

22.228

57.371

Прибыль на акцию

1.57

Рентабельность продаж

-7.53

Сотрудники

423

EBITDA

-20M

71M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+81.67% upside

Дивиденды

By Acuity

Следующий отчет о доходах

5 нояб. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-279M

875M

Предыдущая цена открытия

26.85

Предыдущая цена закрытия

27.33

Новостные настроения

By Acuity

32%

68%

104 / 340 Рейтинг в Healthcare

Collegium Pharmaceutical Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

24 авг. 2026 г., 22:02 UTC

Collegium Pharmaceutical shares advanced in after-market trading, despite being below their 20-day moving average and weaker compared to a month ago.

21 авг. 2026 г., 20:13 UTC

Collegium Pharmaceutical Inc. shares are trading roughly flat after-market, with no specific news identified. The stock remains below its 20-day moving average.

20 авг. 2026 г., 20:01 UTC

Collegium Pharmaceutical shares are lower amid broader market pressures, reflecting negative sentiment following Walmart's disappointing earnings report.

19 авг. 2026 г., 19:56 UTC

Collegium Pharmaceutical Inc. shares are higher since Tuesday's close, reaching a session high earlier before pulling back within routine trading patterns.

18 авг. 2026 г., 19:56 UTC

Collegium Pharmaceutical Inc is trading higher today, though no specific news was identified to explain the movement. The stock remains below its 20-day moving average.

17 авг. 2026 г., 19:36 UTC

Collegium Pharmaceutical Inc shares are higher during Monday's session, reaching a peak gain earlier today before retracing. No specific news was identified for the movement.

14 авг. 2026 г., 19:21 UTC

Collegium Pharmaceutical Inc shares are lower today, reflecting a broader downturn in the Pharmaceuticals sector. The stock remains below its 20-day moving average.

13 авг. 2026 г., 22:51 UTC

Collegium Pharmaceutical Inc shares rose in after-market trading, reflecting broader market gains amid unchanged producer prices and easing inflation expectations.

12 авг. 2026 г., 19:51 UTC

Collegium Pharmaceutical Inc's shares are lower today, continuing a trend of recent weakness amid unusually high market volume. No specific news was identified.

11 авг. 2026 г., 22:01 UTC

Collegium Pharmaceutical Inc shares are higher in after-market trading, reversing earlier session dips and showing strength after three consecutive lower closes.

10 авг. 2026 г., 21:01 UTC

Collegium Pharmaceutical Inc shares are lower in after-market hours, continuing a trend since Monday's close, and are significantly below their 20-day moving average.

7 авг. 2026 г., 21:01 UTC

Collegium Pharmaceutical Inc shares are trading higher in after-market hours. No specific news was identified to explain the movement.

6 авг. 2026 г., 23:11 UTC

Collegium Pharmaceutical Inc shares are higher in after-market hours, recovering from an initial dip but remain below their 20-day moving average.

4 авг. 2026 г., 19:26 UTC

Collegium Pharmaceutical Inc shares are lower today, trading near the lower end of their one-month range, with no specific news driving the decline.

3 авг. 2026 г., 19:46 UTC

Collegium Pharmaceutical Inc is trading lower today, continuing a three-session decline. The stock peaked early but has since pulled back.

31 июл. 2026 г., 20:06 UTC

News

Collegium Pharmaceutical is under scrutiny due to concerns over its financial performance, contributing to a decline in shares during Friday's session.

30 июл. 2026 г., 20:09 UTC

Collegium Pharmaceutical Inc shares are lower in Thursday's session, with no specific news to explain the decline amid broader market volatility.

29 июл. 2026 г., 22:01 UTC

Collegium Pharmaceutical Inc is trading higher in after-market hours, continuing a positive trend with gains over four consecutive sessions amid cautious investor sentiment.

28 июл. 2026 г., 22:01 UTC

Collegium Pharmaceutical Inc shares are lower in after-market hours, continuing a decline from Tuesday's close amid broader market pressures, particularly in Asia.

27 июл. 2026 г., 19:07 UTC

News

Collegium Pharmaceutical reported first-quarter revenues of $193.5 million, surpassing expectations, while shares are trading higher amid broader strength in the pharmaceutical sector.

24 июл. 2026 г., 19:46 UTC

Collegium Pharmaceutical Inc shares are lower during Friday's session, with no specific news identified to explain the decline. The stock remains near its one-month trading range.

22 июл. 2026 г., 20:01 UTC

Collegium Pharmaceutical Inc shares are lower today, continuing a downward trend seen since Tuesday's close, with no specific news identified for the decline.

21 июл. 2026 г., 20:01 UTC

Collegium Pharmaceutical Inc is trading higher amid a broader market rally, with the Pharmaceuticals sector also gaining momentum. No specific news was identified.

20 июл. 2026 г., 19:41 UTC

News

Collegium Pharmaceutical plans to move its headquarters to Boston in 2027. Shares are lower amid significant declines in the Pharmaceuticals sub-sector.

Сравнение c конкурентами

Изменение цены

Collegium Pharmaceutical Inc Прогноз

Целевая цена

By TipRanks

81.67% рост

Прогноз на 12 месяцев

Средняя 49.25 USD  81.67%

Максимум 60 USD

Минимум 43 USD

Основано на мнении 4 аналитиков Wall Street, спрогнозировавших целевые цены для Collegium Pharmaceutical Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

4 ratings

3

Покупка

1

Удержание

0

Продажа

Настроения

By Acuity

104 / 340Рейтинг в Здравоохранение

Новостные настроения

Свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Выше среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Collegium Pharmaceutical Inc

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
help-icon Live chat